Pharmaceuticals

111 results

fDi On Location: Tuscany

Buffalo and Rochester look to up share of New York state spoils

Investment into the state of New York is naturally dominated by New York City, leaving the likes of ...

EU policy threat to clinical trials

Experts are warning that EU policy on clinical trials in Europe could hamper innovation and investment...

US states step-up to join biotech elite

The US biotechnology landscape has changed radically in the 20 years since the first BIO International...

New markets for life sciences sector

While the US continues to take the lion’s share of investment and projects in the biotech and pharmaceutical...

Advertisement

Dubai's free zones: something for everyone

Dubai’s free zones are drawing in businesses unfamiliar with the Middle East, thanks to a combination...

Ontario and Quebec up their biotech games

The leading two provinces for life sciences in Canada are not resting on their laurels when it comes ...

UK top European destination for pharmaceutical investments in 2012

Six pharmaceutical FDI projects have been recorded in the UK in the  first quarter of 2012, making...

Johnson & Johnson takes outsourcing route to business growth

Julia Santos, head of global business optimisation for the Johnson & Johnson Group, explains to ...

An eye on expansion

The global of president Bausch & Lomb’s pharmaceutical division tells Lara Williams how...

Advertisement